trial
as of 2026-07-01Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
NCTId NCT00934908
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by Medical University of South Carolina
Primary completion 2009-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2009-03
Primary completion
2009-03
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Medical University of South CarolinaLead Sponsor
Eli Lilly and CompanyCollaborator
Investigators
2
Jennifer L Donovan, PhDPrincipal Investigator
Thomas W Uhde, MDStudy Chair
Sites
1 total
Charleston, United States
Facts & assertions
4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2009-03
Status
WITHDRAWN
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
investigator
person
person